secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001801170-25-000196
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health Q2 revenue $478M (+34% YoY), membership up 32%, GAAP net loss $11M
--------------------------------------------------------------------------------

- Q2 2025 total revenues $477.6M, up 34% YoY; insurance revenue $469.8M (+34.3%).
- Medicare Advantage membership 106,323 (+32% YoY); avg membership 105,494 (+31.8%).
- GAAP net loss from cont ops $10.6M; Adjusted net income $16.7M; Adjusted EBITDA $17.1M.
- FY2025 guidance: membership raised to 104K-108K; Adj SG&A improved to $335M-$345M; Insurance BER guided to 88.5%-89.5% (from 87%-88%).
- CEO highlights AI-driven clinical recommendations; published COPD whitepaper showing 15% fewer hospitalizations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/0001801170-25-000196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117025000196/clov-20250805.htm
  HTML page:      https://secwatch.observer/filing/0001801170-25-000196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer